JP2021088550A - Liquid oral composition and intraoral bubble-discharging pump product - Google Patents
Liquid oral composition and intraoral bubble-discharging pump product Download PDFInfo
- Publication number
- JP2021088550A JP2021088550A JP2020191746A JP2020191746A JP2021088550A JP 2021088550 A JP2021088550 A JP 2021088550A JP 2020191746 A JP2020191746 A JP 2020191746A JP 2020191746 A JP2020191746 A JP 2020191746A JP 2021088550 A JP2021088550 A JP 2021088550A
- Authority
- JP
- Japan
- Prior art keywords
- foam
- liquid
- oral composition
- liquid oral
- discharged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 78
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 238000007599 discharging Methods 0.000 title claims abstract description 5
- 239000006260 foam Substances 0.000 claims abstract description 65
- 210000000214 mouth Anatomy 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000004094 surface-active agent Substances 0.000 claims abstract description 17
- 239000002562 thickening agent Substances 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims description 22
- 210000003296 saliva Anatomy 0.000 abstract description 11
- -1 aldehyde compound Chemical class 0.000 description 33
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 27
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 239000007789 gas Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000000606 toothpaste Substances 0.000 description 8
- 229940034610 toothpaste Drugs 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 206010013781 dry mouth Diseases 0.000 description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000003899 bactericide agent Substances 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 230000001680 brushing effect Effects 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- UUWJHAWPCRFDHZ-UHFFFAOYSA-N 1-dodecoxydodecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC UUWJHAWPCRFDHZ-UHFFFAOYSA-N 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102100037644 Kelch-like protein 41 Human genes 0.000 description 2
- 108050003242 Kelch-like protein 41 Proteins 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229940042127 oral foam Drugs 0.000 description 2
- NPKKRSHVJIQBKU-UHFFFAOYSA-N ornogenin Natural products CC(OC(=O)C=Cc1ccccc1)C2(O)CCC3(O)C4(O)CC=C5CC(O)CCC5(C)C4CC(OC(=O)C=Cc6ccccc6)C23C NPKKRSHVJIQBKU-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- GRWFGVWFFZKLTI-YGPZHTELSA-N (5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene Chemical compound C1C2CC=C(C)[C@]1([H])C2(C)C GRWFGVWFFZKLTI-YGPZHTELSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- QVFOGJXHRGAFSH-UHFFFAOYSA-N acetic acid;1-dodecoxydodecane Chemical compound CC(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC QVFOGJXHRGAFSH-UHFFFAOYSA-N 0.000 description 1
- JTPLPDIKCDKODU-UHFFFAOYSA-N acetic acid;2-(2-aminoethylamino)ethanol Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.NCCNCCO JTPLPDIKCDKODU-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- QYIXCDOBOSTCEI-FBVYSKEZSA-N epidihydrocholesterin Chemical compound C([C@@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-FBVYSKEZSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- DWYMPOCYEZONEA-UHFFFAOYSA-L fluoridophosphate Chemical compound [O-]P([O-])(F)=O DWYMPOCYEZONEA-UHFFFAOYSA-L 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 229940095683 oral foam product Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- VIZXMHCBZLGUET-UHFFFAOYSA-N sodium gualenate Chemical compound CC(C)C1=CC=C(C)C2=C(S(O)(=O)=O)C=C(C)C2=C1 VIZXMHCBZLGUET-UHFFFAOYSA-N 0.000 description 1
- 229950002760 sodium gualenate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229940117960 vanillin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、液体口腔用組成物に関し、詳しくは泡吐出容器に充填されるための液体口腔用組成物に関する。また、前記液体口腔用組成物が充填された口腔内用泡吐出式ポンプ製品にも関する。 The present invention relates to a liquid oral composition, and more particularly to a liquid oral composition for filling a foam discharge container. It also relates to an intraoral foam discharge pump product filled with the liquid oral composition.
従来、口腔用組成物を含む歯磨用製剤として、粉歯磨き、練歯磨き、液体歯磨き等の剤形が主に用いられてきた。
練歯磨きの場合、歯ブラシ上での保形性が高く、口腔内へ製剤を運ぶという点で優れている。一方で、唾液の分泌が少ない高齢者をはじめとするドライマウスの症状が見られる場合は、口腔内全体に薬剤を拡散させるには時間を要することから、歯をブラッシングする短い時間内では薬剤が拡散しきらない場合があった。また、液体歯磨きの場合、練り歯磨きが抱える課題は解決されるが、口腔機能の低下により洗口および吐き出しが困難な場合は、誤飲や誤嚥の高いリスクがあった。
Conventionally, as a toothpaste preparation containing an oral composition, dosage forms such as powder toothpaste, toothpaste, and liquid toothpaste have been mainly used.
In the case of toothpaste, the shape retention on the toothbrush is high, and it is excellent in that the preparation is carried into the oral cavity. On the other hand, when symptoms of dry mouth such as elderly people with low saliva secretion are observed, it takes time to spread the drug throughout the oral cavity, so the drug should be used within a short time of brushing the teeth. In some cases, it did not spread completely. Further, in the case of liquid toothpaste, the problems of toothpaste are solved, but when it is difficult to wash the mouth and spit out due to deterioration of oral function, there is a high risk of accidental ingestion and aspiration.
そこで、近年では泡状で用いられる製剤に関する口腔用組成物の開発が広く検討されている。例えば、特許文献1では、特定量のアニオン性界面活性剤及び両性界面活性剤と、特定粘度の多糖系天然高分子又は非イオン性半合成高分子と、水とを含む泡吐出容器入り液体口腔用組成物が開示されている。特許文献2では、界面活性剤と、特定の高分子化合物を組み合わせた粘結剤とを含有する泡状口腔用組成物が開示されている。特許文献3では、界面活性剤を0.5〜15%ならびに炭素数7または8のアルデヒド化合物を泡吐出容器に充填した泡状口腔用組成物が開示されている。 Therefore, in recent years, the development of oral compositions for formulations used in foam form has been widely studied. For example, in Patent Document 1, a liquid oral cavity containing a specific amount of anionic surfactant and amphoteric surfactant, a polysaccharide-based natural polymer or nonionic semisynthetic polymer having a specific viscosity, and water is contained in a foam discharge container. The composition for use is disclosed. Patent Document 2 discloses a foamy oral composition containing a surfactant and a binder in which a specific polymer compound is combined. Patent Document 3 discloses a foamy oral composition in which a foam discharge container is filled with 0.5 to 15% of a surfactant and an aldehyde compound having 7 or 8 carbon atoms.
上記特許文献1及び2に記載された液体口腔用組成物は、いずれも、口腔内でも泡が持続して保型性を有するものであり、使用時に泡状にしてブラッシング適用できることを前提としている。さらに、上記特許文献3に記載された泡状口腔用組成物は、香味立ち、起泡性の経時安定性、泡保持性及び泡のきめを向上するものである。
このように、特許文献1〜3では口腔用組成物の泡質については様々な検討がなされているものの、口腔内での拡散性についての具体的な検討はなされていない。
All of the liquid oral compositions described in Patent Documents 1 and 2 are premised on the fact that the foam lasts even in the oral cavity and has a shape-retaining property, and that it can be foamed and brushed at the time of use. .. Further, the foamy oral composition described in Patent Document 3 improves flavoring, foaming stability over time, foam retention and foam texture.
As described above, in Patent Documents 1 to 3, various studies have been made on the foam quality of the oral composition, but no specific study has been made on the diffusibility in the oral cavity.
泡状となる液体口腔用組成物において、泡の保形性(泡質)は重要な要素のひとつであり、すぐに破泡してしまうと、歯ブラシに載せて使用する際に、液ダレが発生してしまう。その一方で、口腔内でも泡の状態が持続すると、有効成分の口腔内への拡散性の低さが懸念される。これは特に、高齢者やドライマウスがみられる者等、口腔内が乾燥気味の者について顕著である。 In a foamy liquid oral composition, the shape retention (foam quality) of the foam is one of the important factors, and if the foam breaks immediately, the liquid will drip when used on a toothbrush. It will occur. On the other hand, if the foamy state continues even in the oral cavity, there is a concern that the active ingredient has low diffusivity into the oral cavity. This is particularly noticeable for people with dry mouth, such as the elderly and those with dry mouth.
本発明は上記事情に鑑みてなされたものであり、口腔内で破泡し、唾液や物理的刺激がなくても口腔内全体に素早く拡散する液体口腔用組成物を提供することを目的とする。 The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a liquid oral composition that ruptures bubbles in the oral cavity and quickly diffuses throughout the oral cavity without saliva or physical irritation. ..
本発明者は鋭意研究を重ねた結果、吐出される泡状物の拡散性を一定値以上とすることにより、上記課題を解決できることを見出し、本発明を完成するに至った。
すなわち本発明は以下のとおりである。
(1)界面活性剤、増粘剤及び水を含み、泡吐出容器に充填されるための液体口腔用組成物であって、吐出された泡状物の拡散性が180%以上であり、乾燥状態にある口腔内に用いられることを特徴とする液体口腔用組成物。
(2)前記吐出された泡状物の液化率が1〜40%であることを特徴とする前記(1)に記載の液体口腔用組成物。
(3)泡状物を吐出するノズル体と、混合された液体及び気体が流通する吐出流路と、を備える泡吐出式ポンプ容器であって、前記ノズル体が液体と気体とを混合する気液混合室を備え、前記吐出流路が網目構造体を備える泡吐出式ポンプ容器に、前記液体として、界面活性剤、増粘剤及び水を含む液体口腔用組成物が充填され、吐出された泡状物の拡散性が180%以上となることを特徴とする乾燥口腔内用泡吐出式ポンプ製品。
As a result of diligent research, the present inventor has found that the above problems can be solved by setting the diffusivity of the discharged foamy substance to a certain value or more, and has completed the present invention.
That is, the present invention is as follows.
(1) A liquid oral composition containing a surfactant, a thickener and water to be filled in a foam discharge container, in which the discharged foam has a diffusivity of 180% or more and is dried. A liquid oral composition characterized by being used in a state of the oral cavity.
(2) The liquid oral composition according to (1) above, wherein the discharged foamy substance has a liquefaction rate of 1 to 40%.
(3) A foam discharge type pump container including a nozzle body for discharging a foamy substance and a discharge flow path through which the mixed liquid and gas flow, and the nozzle body is a gas that mixes the liquid and the gas. A foam discharge pump container provided with a liquid mixing chamber and having a mesh structure for the discharge flow path was filled with a liquid oral composition containing a surfactant, a thickener and water as the liquid, and discharged. A foam discharge pump product for dry oral cavity, characterized in that the diffusivity of foam is 180% or more.
本発明に係る液体口腔用組成物は、乾燥気味の口腔内に用いられた場合であっても、速やかに破泡し、唾液や物理的刺激を伴わなくても良好に口腔内に拡散する。
歯磨きを行う際に、歯ブラシを水で湿らせる等の水分の添加が不要となることから、介護等、他者が歯を磨く際にも使い勝手がよく、さらには、洗浄剤や殺菌剤、抗炎症剤等の各種成分が過剰に希釈されて効果が薄まることも防ぐことができる。
The liquid oral composition according to the present invention quickly ruptures bubbles even when used in a slightly dry oral cavity, and diffuses well into the oral cavity without saliva or physical irritation.
When brushing teeth, it is not necessary to add water such as moistening the toothbrush with water, so it is easy to use when others brush their teeth such as nursing care, and it is also a detergent, bactericide, anti-inflammatory agent. It is also possible to prevent various components such as inflammatory agents from being excessively diluted to diminish the effect.
[液体口腔用組成物]
本発明に係る液体口腔用組成物は、界面活性剤、増粘剤及び水を含み、泡吐出容器に充填されるためのものであり、吐出された泡状物の拡散性が180%以上であって、乾燥状態にある口腔内に用いられることを特徴とする。
[Liquid oral composition]
The liquid oral composition according to the present invention contains a surfactant, a thickener and water, and is intended to be filled in a foam discharge container, and the diffusivity of the discharged foam is 180% or more. It is characterized by being used in the oral cavity in a dry state.
ここで乾燥状態にある口腔内とは、例えば高齢者やドライマウスの者等のように、唾液の分泌量が少ない者の口腔内を意味する。具体的には、ガム試験やサクソン試験により口腔内が乾燥状態にあるか否かを判断することができる。
ガム試験であれば、ガムを噛み、出てくる唾液の量が10分間で10mL以下である場合、サクソン試験であれば、ガーゼを噛み、ガーゼに含まれる唾液の重さが、2分間で2g以下である場合に、口腔内が乾燥状態であると判断することができる。
Here, the dry oral cavity means the oral cavity of a person who secretes a small amount of saliva, such as an elderly person or a dry mouth person. Specifically, it is possible to determine whether or not the oral cavity is in a dry state by a gum test or a Saxon test.
In the gum test, chew gum and the amount of saliva that comes out is 10 mL or less in 10 minutes. In the Saxon test, chew gauze and the weight of saliva contained in the gauze is 2 g in 2 minutes. When the following, it can be determined that the oral cavity is in a dry state.
また、本発明に係る乾燥口腔内用泡吐出式ポンプ製品は、泡吐出式ポンプ容器に前記液体口腔用組成物が充填されてなるものであるが、乾燥口腔内用とは、前記乾燥状態にある口腔内に用いられることと同義である。 Further, the dry oral foam discharge pump product according to the present invention is obtained by filling the foam discharge pump container with the liquid oral composition, but the dry oral foam product is in the dry state. It is synonymous with being used in a certain oral cavity.
<界面活性剤>
界面活性剤は主に洗浄剤や発泡剤として用いられる成分である。具体的には、ノニオン性界面活性剤、アニオン性界面活性剤、両性界面活性剤、及びカチオン性界面活性剤からなる群より選ばれる1種又は複数の界面活性剤を用いることができる。なお、本明細書において、ポリオキシエチレンをPOE、ポリオキシプロピレンをPOPと称することがある。
<Surfactant>
Surfactants are components mainly used as detergents and foaming agents. Specifically, one or more surfactants selected from the group consisting of nonionic surfactants, anionic surfactants, amphoteric surfactants, and cationic surfactants can be used. In the present specification, polyoxyethylene may be referred to as POE, and polyoxypropylene may be referred to as POP.
ノニオン性界面活性剤としては、例えば、POE硬化ヒマシ油;POEラウリルエーテル、POEセチルエーテルやPOEステアリルエーテル等のPOEアルキルエーテル;POE脂肪酸エステル;POEソルビタンヤシ油脂肪酸エステル(POEヤシ油脂肪酸ソルビタンとも言う。)等のPOEソルビタン脂肪酸エステル;POE高級アルコールエーテル;POEアルキルフェニルエーテル;POEフィトステロール;POE・POPセチルエーテル等のPOE・POPアルキルエーテル;POE・POPブロックポリマー;POE・POP脂肪酸エステル;アルキルグリコシド;プロピレングリコール脂肪酸エステル;モノラウリン酸ポリグリセリル等のグリセリン脂肪酸エステル;モノステアリン酸ポリエチレングリコール等のポリエチレングリコール脂肪酸エステル;ソルビタン脂肪酸エステル等が挙げられる。これらは1種を単独で、又は2種以上を用いることができる。
なかでも、POE硬化ヒマシ油、POEアルキルエーテル、POEソルビタン脂肪酸エステル、アルキルグリコシドがカチオン系殺菌剤と併用した際、製剤が安定である点から好ましく、POE硬化ヒマシ油、POEラウリルエーテル、POEヤシ油脂肪酸ソルビタン、アルキルグリコシドがより好ましい。
Examples of the nonionic surfactant include POE-hardened castor oil; POE alkyl ethers such as POE lauryl ether, POE cetyl ether and POE stearyl ether; POE fatty acid esters; POE sorbitan coconut oil fatty acid esters (also referred to as POE coconut oil fatty acid sorbitan). .) Etc. POE sorbitan fatty acid ester; POE higher alcohol ether; POE alkylphenyl ether; POE phytosterol; POE / POP alkyl ether such as POE / POP cetyl ether; POE / POP block polymer; POE / POP fatty acid ester; alkyl glycoside; Examples thereof include propylene glycol fatty acid esters; glycerin fatty acid esters such as polyglyceryl monolaurate; polyethylene glycol fatty acid esters such as polyethylene glycol monostearate; and sorbitan fatty acid esters. These can be used alone or in combination of two or more.
Among them, POE-hardened castor oil, POE alkyl ether, POE sorbitan fatty acid ester, and alkyl glycoside are preferable because the preparation is stable when used in combination with a cationic bactericide, and POE-hardened castor oil, POE lauryl ether, and POE coconut oil are preferable. Fatty acid sorbitan and alkyl glycoside are more preferable.
アニオン性界面活性剤としては、例えば、POEラウリルエーテルリン酸やPOEラウリルエーテルリン酸ナトリウム等のPOEアルキルエーテルリン酸又はPOEアルキルエーテルリン酸塩;POEアルキルエーテル硫酸塩;POEラウリルエーテル酢酸ナトリウム等のアルキルエーテルカルボン酸塩;ラウロイルサルコシンナトリウムやミリストイルサルコシンナトリウム等のN−アシルアミノ酸塩;ラウロイルメチルタウリンナトリウム等のN−アシルタウリン塩;ラウリル硫酸ナトリウムやミリスチル硫酸ナトリウム等のアルキル硫酸塩;スルホコハク酸ジ(2−エチルヘキシル)ナトリウム等のスルホン酸塩;アルキルリン酸塩等が挙げられる。これらは1種を単独で、又は2種以上を用いることができる。
なかでも、N−アシルアミノ酸塩、アルキル硫酸塩、N−アシルタウリン塩が優れた起泡力の点から好ましく、ラウロイルサルコシンナトリウム、ラウリル硫酸ナトリウム、ラウロイルメチルタウリンナトリウムがより好ましい。
Examples of the anionic surfactant include POE alkyl ether phosphate such as POE lauryl ether phosphate and sodium POE lauryl ether phosphate or POE alkyl ether phosphate; POE alkyl ether sulfate; and POE sodium lauryl ether acetate. Alkyl ether carboxylate; N-acyl amino acid salts such as sodium lauroyl sarcosin and sodium myristyl sarcosin; N-acyl taurine salts such as sodium lauroyl methyl taurine; alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate; di sulfosuccinate (di (sulfosuccinate) 2-Ethylhexyl) Sulfates such as sodium; alkyl phosphates and the like can be mentioned. These can be used alone or in combination of two or more.
Among them, N-acylamino acid salt, alkyl sulfate and N-acyl taurine salt are preferable from the viewpoint of excellent foaming power, and sodium lauroyl sarcosine, sodium lauryl sulfate and sodium lauroyl methyl taurine are more preferable.
両性界面活性剤としては、ベタイン型、グリシン型のいずれも用いることができる。中でもアルキルベタイン型又はグリシン型が好ましく、例えば、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、ヤシ油脂肪酸アミドプロピルベタイン、ラウリルジアミノエチルグリシンナトリウム、ラウリルジメチルアミノ酢酸ベタイン等が挙げられる。これらは1種を単独で、又は2種以上を用いることができる。 As the amphoteric surfactant, either a betaine type or a glycine type can be used. Of these, alkyl betaine type or glycine type is preferable, and for example, 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, coconut oil fatty acid amide propyl betaine, lauryl diaminoethyl glycine sodium, lauryl dimethyl amino acetate betaine and the like are preferable. Can be mentioned. These can be used alone or in combination of two or more.
カチオン性界面活性剤としては、塩化セチルピリジニウム、塩化ベンザルコニム、塩化ベンゼトニウム、塩化アルキルトリメチルアンモニウム、塩化ジアルキルジメチルアンモニウム、POEアルキルアミン・脂肪酸アミド等が挙げられる。これらは1種を単独で、又は2種以上を用いることができる。 Examples of the cationic surfactant include cetylpyridinium chloride, benzalconium chloride, benzethonium chloride, alkyltrimethylammonium chloride, dialkyldimethylammonium chloride, POE alkylamine / fatty acid amide and the like. These can be used alone or in combination of two or more.
界面活性剤は、液体口腔用組成物の液化率に寄与する成分であると考えられる。すなわち、液体口腔用組成物を泡状に吐出した際の保形性に寄与する。液化率を低くすることで泡状物の保形性が高まり、歯ブラシに泡状物を吐出した際の液ダレを抑制することができる。
上記観点から、界面活性剤として、ノニオン性界面活性剤を含むことが好ましく、具体的には、POE硬化ヒマシ油、POEラウリルエーテル、POEヤシ油脂肪酸ソルビタン、アルキルグリコシドからなる群より選ばれる少なくとも1種以上を用いることがより好ましい。また、界面活性剤の含有量は、合計で0.01質量%以上が好ましく、0.1質量%以上がより好ましく、また、10質量%以下が好ましく、5質量%以下がより好ましく、4質量%以下がさらに好ましい。
Surfactants are considered to be components that contribute to the liquefaction rate of liquid oral compositions. That is, it contributes to the shape retention when the liquid oral composition is discharged in the form of bubbles. By lowering the liquefaction rate, the shape-retaining property of the foamy substance is enhanced, and it is possible to suppress the liquid dripping when the foamy substance is discharged to the toothbrush.
From the above viewpoint, the surfactant preferably contains a nonionic surfactant, and specifically, at least one selected from the group consisting of POE-hardened castor oil, POE lauryl ether, POE coconut oil fatty acid sorbitan, and alkyl glycoside. It is more preferable to use seeds or more. The total content of the surfactant is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, preferably 10% by mass or less, more preferably 5% by mass or less, and 4% by mass. % Or less is more preferable.
<増粘剤>
増粘剤も、液体口腔用組成物の液化率に寄与する成分であると考えられる。増粘剤としては、カルボキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、キサンタンガム、グァーガム、カラギーナン、ジェランガム、ペクチン、ローカストビーンガム、デンプン、デキストリン等が挙げられ、カルボキシメチルセルロース、ヒドロキシエチルセルロース、キサンタンガム、ジェランガムからなる群より選ばれる少なくとも1種以上を用いることが好ましい。中でもヒドロキシエチルセルロース、キサンタンガムがより好ましく、ヒドロキシエチルセルロースがさらに好ましい。
また、その含有量は合計で0.01質量%以上が好ましく、0.05質量%以上がより好ましく、また、1質量%以下が好ましく、0.5質量%以下がより好ましい。
<Thickener>
Thickeners are also considered to be components that contribute to the liquefaction rate of liquid oral compositions. Examples of the thickener include carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, xanthan gum, guar gum, carrageenan, gellan gum, pectin, locust bean gum, starch, dextrin and the like. It is preferable to use at least one selected from the above. Of these, hydroxyethyl cellulose and xanthan gum are more preferable, and hydroxyethyl cellulose is even more preferable.
The total content thereof is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, preferably 1% by mass or less, and more preferably 0.5% by mass or less.
<その他の成分>
本発明に係る液体口腔用組成物には、溶剤である水の他、発明の効果を損なわない限り、その他の各種成分を配合することができる。
例えば、エタノール等のアルコール;グリセリン、プロピレングリコール、ソルビトール、ポリエチレングリコール等の湿潤剤;ステビオサイド、キシリトール、エリスリトール、ソルビトール、スクラロース、トレハロース、サッカリンナトリウム、ステビア等の甘味料;アズレン、アズレンスルホン酸塩、β−グリチルレチン酸、グリチルリチン酸及び塩類、ジヒドロコレステロール、エピジヒドロコレステリン、酢酸dl−α−トコフェロール、ニコチン酸dl−α−トコフェロール、ε−アミノカプロン酸、トラネキサム酸等の抗炎症剤;塩化リゾチーム、デキストラナーゼ、ムタナーゼ、プロテアーゼ等の酵素;フッ化ナトリウム、フッ化第一スズ、フルオロリン酸塩、フルオロホウ酸塩等のフッ素イオン源;リン酸カルシウム、ハイドロキシアパタイト等のリン酸イオン源;メトキシエチレン無水マレイン酸共重合体塩、塩化亜鉛、有機酸亜鉛等の歯石予防剤;ヒノキチオール、アラントイン、アラントインクロルヒドロキシアルミニウム、アラントインジヒドロキシアルミニウム、塩化ナトリウム等の収斂剤;パラヒドロキシ安息香酸エステル、安息香酸ナトリウム等の防腐剤;エチレンジアミンヒドロキシエチル三酢酸塩、エデト酸及びその塩類、グルコノデルタラクトン、グルコン酸、ヒドロキシエチルエチレンジアミン三酢酸塩、ピロリン酸塩、ポリリン酸塩、メタリン酸塩、アラニン、クエン酸及びその塩類、又は酒石酸及びその塩類等のキレート剤;リン酸一水素ナトリウム、リン酸二水素ナトリウム、クエン酸、クエン酸ナトリウム等のpH調整剤;ペパーミント油、ハッカ油、メントール、カルバクロール、ユーカリオイル、オイゲノール、アネトール、シネオール、ヒノキチオール、チモール、ピネン、ペパーミントオイル、シナモンオイル、クローブオイル、オイゲノール、レモンオイル、バニリン、シネオール、ユーカリオイル等の香料成分;オウバクエキス、トウキエキス等の生薬;青色1号、黄色5号、黄色4号、黄色202(1)号、赤色102号、緑色3号、緑色201号、銅クロロフィリンナトリウム等の着色剤;イソプロピルメチルフェノール、トリクロサン等の殺菌剤等が挙げられる。
<Other ingredients>
In addition to water as a solvent, the liquid oral composition according to the present invention may contain various other components as long as the effects of the present invention are not impaired.
For example, alcohols such as ethanol; wetting agents such as glycerin, propylene glycol, sorbitol, polyethylene glycol; sweeteners such as stebioside, xylitol, erythritol, sorbitol, sclorose, trehalose, sodium saccharin, stevia; azulene, azulene sulfonate, β- Anti-inflammatory agents such as glycyrrhetinic acid, glycyrrhizinic acid and salts, dihydrocholesterol, epidihydrocholesterin, dl-α-tocopherol acetate, dl-α-tocopherol nicotinate, ε-aminocaproic acid, tranexamic acid; lysoteam chloride, dextranase , Mutanase, protease and other enzymes; fluorine ion sources such as sodium fluoride, stannous fluoride, fluorophosphate and fluoroborate; phosphate ion sources such as calcium phosphate and hydroxyapatite; Toothstone preventives such as coalesced salt, zinc chloride, zinc organic acid; astringents such as hinokithiol, allantin, allantinchlorohydroxyaluminum, allantindihydroxyaluminum, sodium chloride; preservatives such as parahydroxybenzoic acid ester, sodium benzoate; ethylenediamine Hydroxyethyl triacetate, edetonic acid and its salts, gluconodeltalactone, gluconic acid, hydroxyethylethylenediamine triacetate, pyrophosphate, polyphosphate, metaphosphate, alanine, citric acid and its salts, or tartrate and Chelating agents such as salts; pH adjusters such as sodium monohydrogen phosphate, sodium dihydrogen phosphate, citric acid, sodium citrate; peppermint oil, peppermint oil, menthol, carbachlor, eucalyptus oil, eugenol, anetol, cineole , Hinokithiol, Timor, Pinen, Peppermint Oil, Cinnamon Oil, Clove Oil, Eugenol, Lemon Oil, Vanillin, Cineol, Eucalyptus Oil, etc. Coloring agents such as No. 4, Yellow No. 202 (1), Red No. 102, Green No. 3, Green No. 201, and sodium copper chlorophyllin; bactericides such as isopropylmethylphenol and triclosan can be mentioned.
<拡散性>
本発明に係る液体口腔用組成物を吐出した泡状物の拡散性は180%以上が好ましく、280%以上がより好ましい。なお、本明細書における泡状物とは、泡吐出式ポンプ容器から吐出された泡状物を意味する。
泡吐出式ポンプ容器とは、泡状物を吐出するノズル体と、混合された液体及び気体が流通する吐出流路と、を備える。前記ノズル体は、液体と気体とを混合する気液混合室を備え、前記吐出流路は、網目構造体を備える。
<Diffusiveness>
The diffusivity of the foamy substance discharged from the liquid oral composition according to the present invention is preferably 180% or more, more preferably 280% or more. The foamy substance in the present specification means a foamy substance discharged from the foam discharge type pump container.
The foam discharge type pump container includes a nozzle body for discharging foam and a discharge flow path through which mixed liquids and gases flow. The nozzle body includes a gas-liquid mixing chamber that mixes a liquid and a gas, and the discharge flow path includes a network structure.
泡状物の拡散性は、用いる泡吐出式ポンプ容器によっても調整することができ、例えば、網目構造体により調整することができる。
網目構造体の網目は、泡状物の高い拡散性を得る点から380メッシュ以下が好ましく、300メッシュ以下がより好ましい。一方、液化率の点から、網目は70メッシュ以上が好ましく、100メッシュ以上がより好ましい。なお、メッシュとは、1インチ(約25.4mm)あたりの縦糸若しくは横糸の数であり、縦糸と横糸の数は同じとする。
The diffusivity of the foam can also be adjusted by the foam discharge type pump container used, for example, by a mesh structure.
The mesh of the network structure is preferably 380 mesh or less, more preferably 300 mesh or less, from the viewpoint of obtaining high diffusivity of foamy substances. On the other hand, from the viewpoint of liquefaction rate, the mesh is preferably 70 mesh or more, and more preferably 100 mesh or more. The mesh is the number of warp threads or weft threads per inch (about 25.4 mm), and the number of warp threads and weft threads is the same.
網目構造体の開き目は、泡状物の高い拡散性を得る点から40μm以上の網状体を用いるのが好ましく、50μm以上がより好ましい。一方、泡状物の液化率の点から、200μm以下が好ましく、150μm以下がより好ましい。なお、開き目とは、縦糸同士又は横糸同士の間隔を意味する。 The opening of the network structure is preferably 40 μm or more, more preferably 50 μm or more, from the viewpoint of obtaining high diffusivity of the foamy substance. On the other hand, from the viewpoint of the liquefaction rate of the foam, 200 μm or less is preferable, and 150 μm or less is more preferable. The opening means the distance between the warp threads or the weft threads.
また、泡吐出式ポンプ容器には、網目構造体が複数存在する場合がある。例えば、泡吐出直前に2か所、上部と下部に網目構造体が使用される場合は、それらの網目を液状の製剤が流通することにより微細な泡となって吐出される。ここで、上部の網目構造体とは、泡吐出口側に位置するものを意味し、下部の網目構造体とは、容器本体側に位置するものを意味する。したがって、液状の製剤は下部網目構造体、上部網目構造体を順に経て、泡として吐出口より吐出される。本明細書において、上部網目構造体の網目が250メッシュ、下部網目構造体の網目が200メッシュを備えた泡吐出式ポンプ容器を用いて泡状物を吐出する場合には、「メッシュサイズ#250/200」と表記する。
なお、上記では網目構造体が2つ存在する場合について記載したが、網目構造体は3か所以上に使用されていてもよい。
Further, the foam discharge type pump container may have a plurality of mesh structures. For example, when a mesh structure is used at two places immediately before the foam is discharged, the upper part and the lower part, the liquid preparation is circulated through the mesh and the fine bubbles are discharged. Here, the upper mesh structure means a structure located on the foam discharge port side, and the lower mesh structure means a structure located on the container body side. Therefore, the liquid formulation passes through the lower network structure and the upper network structure in this order, and is discharged as bubbles from the discharge port. In the present specification, when foamy substances are discharged using a foam discharge type pump container having a mesh of the upper mesh structure of 250 mesh and a mesh of the lower mesh structure of 200 mesh, "mesh size # 250". Notated as "/ 200".
In addition, although the case where there are two mesh structures is described above, the mesh structure may be used in three or more places.
このように、網目構造体を複数備える泡吐出式ポンプ容器を使用してもよく、それらの網目及び開き目は、同一のものを組み合わせても、異なるものを組み合わせて用いてもよい。網目構造体を所望間隙を有して配置することにより、液体口腔用組成物からなる泡状物の拡散性や液化率を調整することもできる。 As described above, a foam discharge type pump container provided with a plurality of mesh structures may be used, and the same mesh and openings may be used in combination or different ones may be used in combination. By arranging the network structure with a desired gap, it is possible to adjust the diffusivity and liquefaction rate of the foamy substance composed of the liquid oral composition.
液体口腔用組成物を吐出した泡状物がかかる拡散性を有することにより、乾燥状態にある口腔内においても、速やかに破泡することによって、唾液や物理的刺激を伴わなくても、良好に口腔内全体に液体口腔用組成物が拡散する。
さらに、歯磨きを行う際に、歯ブラシを水で湿らせる等の水分の添加が不要となる。これにより、乳幼児や高齢者等の補助や介護を必要とする者が、他者により歯を磨いてもらう際にも使い勝手がよく、誤嚥を防止したり、最小限のすすぎで済ませることができるため好ましい。さらには、洗浄剤や殺菌剤、抗炎症剤等の各種成分が希釈されて効果が薄まることも防ぐことができる。
Due to the diffusivity of the foamy substance discharged from the liquid oral composition, the foam can be rapidly ruptured even in the dry oral cavity without saliva or physical irritation. The liquid oral composition diffuses throughout the oral cavity.
Further, when brushing teeth, it is not necessary to add water such as moistening the toothbrush with water. As a result, it is easy for those who need assistance or care such as infants and the elderly to brush their teeth by others, and it is possible to prevent aspiration and minimize rinsing. Therefore, it is preferable. Furthermore, it is possible to prevent various components such as detergents, bactericides, and anti-inflammatory agents from being diluted to dilute the effect.
一方、拡散性が高く液化率も高すぎると、吐出した泡状物の保形性が低くなり、歯ブラシ上に吐出された泡状物が、口腔内に運ばれる前に液ダレするおそれがある。そのため、吐出した泡状物の拡散性には好ましい上限があるものの、実際にはかかる拡散性の値は頭打ちとなる。そこで、液ダレに関する指標として、前記拡散性の上限に代えて、後述する液化率で評価することができる。 On the other hand, if the diffusivity is high and the liquefaction rate is too high, the shape-retaining property of the discharged foam is low, and the foam discharged on the toothbrush may drip before being carried into the oral cavity. .. Therefore, although there is a preferable upper limit to the diffusivity of the discharged foam, the diffusivity value actually reaches a plateau. Therefore, as an index related to liquid dripping, the liquefaction rate described later can be used instead of the upper limit of the diffusibility.
なお、拡散性は先述したように、例えば増粘剤の種類や含有量によって調整することができる。また、エタノール等のアルコール、ポリエチレングリコール等の湿潤剤によっても調整することができる。 As described above, the diffusibility can be adjusted by, for example, the type and content of the thickener. It can also be adjusted with an alcohol such as ethanol and a wetting agent such as polyethylene glycol.
拡散性は、下記手順により豚舌を用いた試験から、確認することができる。
まず、豚舌(必要に応じて舌筋を切断し豚舌表面が試験台と平行になるよう加工したもの)を流水で軽く洗浄した後、豚舌表面の水分を除去する。かかる水分の除去によりドライマウス状態を再現するが、水分除去後の豚舌表面における水分量が、口腔水分計 ムーカス(株式会社ライフ製、商品名)で測定した際に、15以上25未満となるまで、水分を除去する。
豚舌の表面に円柱状の筒を設置し、その中に液体口腔用組成物を泡状に吐出する。この泡状物と豚舌との接触面積は、前記円柱状の筒により固定されるため、これを初期の泡性状と規定し、その接触面積を初期接触面積とする。
次いで、泡状物を吐出し、筒を外してから2分経過した後、泡状物と豚舌との接触面積を測定し、2分経過後の接触面積とする。上記初期接触面積と2分経過後の接触面積とから、下記式により拡散性(%)を算出する。
拡散性(%)=(2分経過後の接触面積/初期接触面積)×100
Diffusibility can be confirmed from a test using a pig tongue by the following procedure.
First, the tongue of the pig (the muscle of the tongue is cut if necessary and processed so that the surface of the tongue is parallel to the test table) is lightly washed with running water, and then the water on the surface of the tongue is removed. The dry mouth state is reproduced by removing the water, but the amount of water on the surface of the pig tongue after the water is removed is 15 or more and less than 25 when measured with the oral moisture meter Mucus (manufactured by Life Co., Ltd., trade name). Remove water until.
A columnar cylinder is placed on the surface of the pig tongue, and the liquid oral composition is discharged into the foam. Since the contact area between the foam and the pig tongue is fixed by the columnar cylinder, this is defined as the initial foam property, and the contact area is defined as the initial contact area.
Next, the foamy substance is discharged, and after 2 minutes have passed since the cylinder was removed, the contact area between the foamy substance and the pig tongue is measured and used as the contact area after 2 minutes have passed. From the initial contact area and the contact area after 2 minutes, the diffusibility (%) is calculated by the following formula.
Diffusibility (%) = (contact area after 2 minutes / initial contact area) x 100
<液化率>
本発明に係る液体口腔用組成物を吐出した泡状物の液化率は1%以上が好ましく、2%以上がより好ましい。また、液化率は40%以下が好ましく、20%以下がより好ましく、さらに15%以下が好ましい。液化率が40%以下であることにより、口腔外における泡の保形性が良好になり、吐出した泡状物を口腔内に運ぶまでに液ダレの発生をより抑制することができる。また、液化率を1%以上とすることにより、口腔内で破泡し、拡散性をより良好なものとすることができる。
<Liquefaction rate>
The liquefaction rate of the foamy substance discharged from the liquid oral composition according to the present invention is preferably 1% or more, more preferably 2% or more. The liquefaction rate is preferably 40% or less, more preferably 20% or less, and further preferably 15% or less. When the liquefaction rate is 40% or less, the shape-retaining property of the foam outside the oral cavity is improved, and the occurrence of liquid dripping can be further suppressed before the discharged foamy substance is carried into the oral cavity. Further, by setting the liquefaction rate to 1% or more, bubbles can be ruptured in the oral cavity and the diffusibility can be improved.
なお、液化率は先述したように、例えば界面活性剤の種類や含有量によって調整することができる。また、エタノール等のアルコール、ポリエチレングリコール等の湿潤剤、塩類等によっても調整することができる。 As described above, the liquefaction rate can be adjusted, for example, by the type and content of the surfactant. It can also be adjusted with alcohols such as ethanol, wetting agents such as polyethylene glycol, salts and the like.
液化率は、下記手順により確認することができる。
50mL円錐型液量計に液体口腔用組成物を約4g、泡状に吐出する。この際の重量を全吐出組成物重量とする。次いで30秒間静置した後、液化した組成物をパスツールピペットで採取し、その重量を液化組成物重量として測定する。上記全吐出組成物重量と液化組成物重量とから、下記式により液化率(%)を算出する。
液化率(%)=(液化組成物重量/全吐出組成物重量)×100
The liquefaction rate can be confirmed by the following procedure.
About 4 g of the liquid oral composition is discharged into a 50 mL conical liquid meter in the form of bubbles. The weight at this time is taken as the total discharge composition weight. Then, after allowing to stand for 30 seconds, the liquefied composition is collected with a Pasteur pipette, and the weight thereof is measured as the weight of the liquefied composition. The liquefaction rate (%) is calculated from the total weight of the discharged composition and the weight of the liquefied composition by the following formula.
Liquefaction rate (%) = (weight of liquefied composition / weight of total discharge composition) x 100
上記液体口腔用組成物を用いる際には、歯磨用液体製剤として泡吐出容器に充填し、泡状物を歯ブラシ上に吐出する。
このように泡状となった液体口腔用組成物は、口腔内での拡散性に優れることから、高齢者やドライマウスの者等、唾液が少なく口腔内が乾燥状態にある者に好適に用いられる。ただし、唾液量が十分である者に用いることを何ら排除するものではない。
When the above liquid oral composition is used, it is filled in a foam discharge container as a liquid preparation for toothpaste, and the foam is discharged onto a toothbrush.
Since the liquid oral composition in the form of foam is excellent in diffusivity in the oral cavity, it is preferably used for elderly people, dry mouths, and other persons who have little saliva and have a dry oral cavity. Be done. However, it does not exclude the use for those who have a sufficient amount of saliva.
また、歯磨きをする際に、歯ブラシを水で湿らせる等の水分の添加が不要となることから、誤嚥を防止したり、最小限のすすぎで済ませることができる。そのため、乳幼児や高齢者等、補助や介護を必要とする者が、他者により歯を磨いてもらう際にも有効である。
さらに、使用時に水分の添加が不要であることから、液体口腔用組成物中に含まれる洗浄剤や殺菌剤、抗炎症剤等の各種成分が希釈されて効果が薄まることも防ぐことができる。
Further, when brushing teeth, it is not necessary to add water such as moistening the toothbrush with water, so that aspiration can be prevented and the minimum rinsing can be performed. Therefore, it is also effective for those who need assistance or long-term care, such as infants and the elderly, to have others brush their teeth.
Further, since it is not necessary to add water at the time of use, it is possible to prevent various components such as a cleaning agent, a bactericide, and an anti-inflammatory agent contained in the liquid oral composition from being diluted to dilute the effect.
[口腔内用泡吐出式ポンプ製品]
本発明は、上記液体口腔用組成物が充填された口腔内用泡吐出式ポンプ製品、好ましくは乾燥口腔内用泡吐出式ポンプ製品にも関する。具体的には、泡吐出式ポンプ容器に、界面活性剤、増粘剤及び水を含む液体口腔用組成物が充填され、吐出された泡状物の拡散性が180%以上となることを特徴とする。
泡吐出式ポンプ容器とは、泡状物を吐出するノズル体と、混合された液体口腔用組成物及び気体が流通する吐出流路と、を備える。前記ノズル体は、液体口腔用組成物と気体とを混合する気液混合室を備え、前記吐出流路は、網目構造体を備えるものである。
泡吐出式ポンプ容器として一態様を以下に示すが、かかる構成に限定されず、従来公知の泡吐出式ポンプ容器を用いることができる。
[Foam discharge pump product for oral cavity]
The present invention also relates to an intraoral foam discharge pump product filled with the above liquid oral composition, preferably a dry oral foam discharge pump product. Specifically, the foam discharge type pump container is filled with a liquid oral composition containing a surfactant, a thickener and water, and the discharged foam has a diffusivity of 180% or more. And.
The foam discharge type pump container includes a nozzle body that discharges a foamy substance, and a discharge flow path through which a mixed liquid oral composition and a gas flow. The nozzle body includes a gas-liquid mixing chamber that mixes a liquid oral composition and a gas, and the discharge flow path includes a network structure.
One aspect of the foam discharge type pump container is shown below, but the configuration is not limited to this, and a conventionally known foam discharge type pump container can be used.
泡吐出式ポンプ容器は、上方を開口した容器本体と、該容器本体の開口部に着脱可能に冠着され、容器本体内に充填された液体口腔用組成物を泡状物として吐出させるノズル体とで構成される。 The foam discharge type pump container is a nozzle body that is detachably attached to a container body having an upper opening and an opening of the container body, and discharges a liquid oral composition filled in the container body as a foam. Consists of.
ノズル体では、空気用シリンダから送出された空気と、液用シリンダから送出された液体口腔用組成物とが気液混合室で合流し、混合される。その後、混合された液体及び気体は、ノズルヘッド内の吐出流路を流通するが、係る吐出流路内に網目構造体を備える。 In the nozzle body, the air delivered from the air cylinder and the liquid oral composition delivered from the liquid cylinder are merged and mixed in the gas-liquid mixing chamber. After that, the mixed liquid and gas flow through the discharge flow path in the nozzle head, and a network structure is provided in the discharge flow path.
網目構造体の網目や開き目については先述したとおりであるが、網目構造体は、液体口腔用組成物と空気とが混合されて流通する流路に備えられればよく、配置する場所や数は任意である。 The meshes and openings of the network structure are as described above, but the network structure may be provided in the flow path where the liquid oral composition and air are mixed and circulated, and the place and number of the network structures may be arranged. It is optional.
以下、本発明を実施例及び比較例によりさらに説明するが、本発明はこれらに制限されるものではない。 Hereinafter, the present invention will be further described with reference to Examples and Comparative Examples, but the present invention is not limited thereto.
<実施例1〜9及び比較例1>
表1に示す配合処方に従って各種成分を混合し、実施例1〜9及び比較例1に係る液体口腔用組成物をそれぞれ調製した。なお、表1中の配合処方を示す数値は質量部表示である。
具体的には、まず50℃に加温した状態で、ヒドロキシエチルセルロース水溶液、濃グリセリン、及び精製水以外の成分を混合した。次いで、常温に戻した後、適宜香料を加えてヒドロキシエチルセルロース水溶液、濃グリセリン、及び精製水を混合することにより、液体口腔用組成物を得た。
<Examples 1 to 9 and Comparative Example 1>
Various components were mixed according to the formulation shown in Table 1 to prepare liquid oral compositions according to Examples 1 to 9 and Comparative Example 1, respectively. In addition, the numerical value which shows the compounding prescription in Table 1 is a mass part display.
Specifically, first, the components other than the aqueous hydroxyethyl cellulose solution, concentrated glycerin, and purified water were mixed in a state of being heated to 50 ° C. Then, after returning to room temperature, a liquid oral composition was obtained by appropriately adding a fragrance and mixing the aqueous hydroxyethyl cellulose solution, concentrated glycerin, and purified water.
<拡散性>
液体口腔用組成物の拡散性の評価を下記手順により行った。
豚舌(必要に応じて舌筋を切断し豚舌表面が試験台と平行になるよう加工したもの)を流水で軽く洗浄した後、豚舌表面の水分をキムタオル(日本製紙クレシア株式会社製、商品名)で除去した。かかる水分の除去によりドライマウス状態を再現するが、水分除去後の豚舌表面における水分量が、口腔水分計 ムーカス(株式会社ライフ製、商品名)で測定した際に、15以上20未満であることより、水分を十分に除去できたことを確認した。
豚舌の表面に円柱状の筒を設置し、その中に液体口腔用組成物を、メッシュサイズ#255/200を用いて泡状に2プッシュ(約0.8g)吐出した。この泡状物と豚舌との接触面積は、前記円柱状の筒により4.86cm2に固定され、これを初期の泡性状と規定し、初期接触面積を4.86cm2とした。
次いで、泡状物を吐出し筒を外してから2分経過した後、泡状物と豚舌との接触面積(2分経過後の接触面積)を、画像処理ソフトウェアであるImage Jを用いて撮影画像より測定した。そして、上記初期接触面積と2分経過後の接触面積とから、下記式により拡散性(%)を算出した。
拡散性(%)=(2分経過後の接触面積)/初期接触面積)×100
結果を表1にまとめて示すが、判定基準は以下のとおりであり、○又は△であれば合格である。
○:拡散性が280%以上であり、非常に良好である。
△:拡散性が180%以上280%未満であり、良好である。
×:拡散性が180%未満であり、不足している。
<Diffusiveness>
The diffusivity of the liquid oral composition was evaluated by the following procedure.
After lightly washing the pig tongue (the tongue muscle is cut if necessary and processed so that the surface of the pig tongue is parallel to the test table) with running water, the water on the surface of the pig tongue is removed from Kim Towel (manufactured by Nippon Paper Crecia Co., Ltd.). Removed with (trade name). The dry mouth state is reproduced by removing such water, but the amount of water on the surface of the pig tongue after removing the water is 15 or more and less than 20 when measured with an oral moisture meter Mucus (manufactured by Life Co., Ltd., trade name). From this, it was confirmed that the water could be sufficiently removed.
A columnar cylinder was placed on the surface of the pig tongue, and the liquid oral composition was discharged into the liquid oral composition by 2 pushes (about 0.8 g) in the form of bubbles using mesh size # 255/200. The contact area between the foam and the pig tongue was fixed at 4.86 cm 2 by the columnar cylinder, which was defined as the initial foam property, and the initial contact area was 4.86 cm 2 .
Next, after 2 minutes have passed since the foamy substance was discharged and the cylinder was removed, the contact area between the foamy substance and the pig tongue (contact area after 2 minutes passed) was determined using Image J, which is image processing software. It was measured from the captured image. Then, the diffusivity (%) was calculated from the initial contact area and the contact area after 2 minutes by the following formula.
Diffusibility (%) = (contact area after 2 minutes) / initial contact area) x 100
The results are summarized in Table 1, and the criteria are as follows. If ○ or Δ, the result is acceptable.
◯: Diffusibility is 280% or more, which is very good.
Δ: The diffusibility is 180% or more and less than 280%, which is good.
X: Diffusibility is less than 180%, which is insufficient.
<液化率>
液体口腔用組成物の液化率の評価を下記手順により行った。
50mL円錐型液量計に液体口腔用組成物を、メッシュサイズ#255/200を用いて泡状に10プッシュ(約4g)吐出した。この際の重量を全吐出組成物重量とする。次いで30秒間静置した後、液化した組成物をパスツールピペットで採取し、その重量を液化組成物重量として測定した。上記全吐出組成物重量と液化組成物重量とから、下記式により液化率(%)を算出した。
液化率(%)=(液化組成物重量/全吐出組成物重量)×100
結果を表1にまとめて示すが、判定基準は以下のとおりであり、○又は△であることが好ましい。
○:液化率が20%以下であり、泡状物の保形性は良好である。
△:液化率が20%超40%以下であり、泡状物の保形性は使用水準に達する。
×:液化率が40%超であり、泡状物の保形性は使用水準に達しない。
<Liquefaction rate>
The liquefaction rate of the liquid oral composition was evaluated by the following procedure.
The liquid oral composition was dispensed into a 50 mL conical liquid meter using 10 pushes (about 4 g) in the form of bubbles using mesh size # 255/200. The weight at this time is taken as the total discharge composition weight. Then, after allowing to stand for 30 seconds, the liquefied composition was collected with a Pasteur pipette, and the weight thereof was measured as the weight of the liquefied composition. The liquefaction rate (%) was calculated from the total weight of the discharged composition and the weight of the liquefied composition by the following formula.
Liquefaction rate (%) = (weight of liquefied composition / weight of total discharge composition) x 100
The results are summarized in Table 1, and the criteria are as follows, preferably ◯ or Δ.
◯: The liquefaction rate is 20% or less, and the shape retention of the foam is good.
Δ: The liquefaction rate is more than 20% and 40% or less, and the shape retention of the foamy substance reaches the usage level.
X: The liquefaction rate is more than 40%, and the shape retention of the foam does not reach the usage level.
以上より、液体口腔用組成物の拡散性を180%以上とすることにより、口腔内が乾燥状態にある場合であっても、泡状物としてかかる液体口腔用組成物を導入した後、水分の添加や唾液、物理的刺激等がなくても口腔内全体に素早く成分を拡散可能であることが示された。また、上記効果は界面活性剤の種類によらず得られることが示された。 Based on the above, by setting the diffusivity of the liquid oral composition to 180% or more, even when the oral cavity is in a dry state, after introducing the liquid oral composition as a foam, the moisture content is reduced. It was shown that the components can be quickly diffused throughout the oral cavity without addition, saliva, physical irritation, etc. Moreover, it was shown that the above effect can be obtained regardless of the type of surfactant.
Claims (3)
吐出された泡状物の拡散性が180%以上であり、
乾燥状態にある口腔内に用いられることを特徴とする液体口腔用組成物。 A liquid oral composition that contains a surfactant, a thickener and water and is to be filled in a foam discharge container.
The diffusivity of the discharged foam is 180% or more,
A liquid oral composition characterized by being used in a dry oral cavity.
前記液体として、界面活性剤、増粘剤及び水を含む液体口腔用組成物が充填され、
吐出された泡状物の拡散性が180%以上となることを特徴とする乾燥口腔内用泡吐出式ポンプ製品。
A foam discharge type pump container including a nozzle body for discharging foam and a discharge flow path through which mixed liquid and gas flow, and a gas-liquid mixing chamber in which the nozzle body mixes liquid and gas. In a foam discharge type pump container in which the discharge flow path is provided with a mesh structure.
As the liquid, a liquid oral composition containing a surfactant, a thickener and water is filled.
A foam discharge pump product for dry oral cavity, characterized in that the diffusivity of the discharged foam is 180% or more.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019214680 | 2019-11-27 | ||
JP2019214680 | 2019-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021088550A true JP2021088550A (en) | 2021-06-10 |
Family
ID=76219439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020191746A Pending JP2021088550A (en) | 2019-11-27 | 2020-11-18 | Liquid oral composition and intraoral bubble-discharging pump product |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2021088550A (en) |
-
2020
- 2020-11-18 JP JP2020191746A patent/JP2021088550A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112135600A (en) | Foaming oral care compositions | |
JPWO2008059881A1 (en) | Composition for oral cavity comprising crystalline cellulose surface-treated with water-soluble substance | |
US20050244346A1 (en) | Composition for oral cavity | |
JP2009084277A (en) | Dentifrice composition | |
JP5233399B2 (en) | Oral spray composition and oral preparation | |
JPH10251131A (en) | Composition for oral cavity | |
JP2007197393A (en) | Dentifrice | |
JP3487023B2 (en) | Foam oral composition | |
JP2021088550A (en) | Liquid oral composition and intraoral bubble-discharging pump product | |
JP2007070256A (en) | Dentifrice composition | |
CN114028273A (en) | Tooth cleaning composition | |
JP7347916B2 (en) | dentifrice composition | |
JP3814142B2 (en) | Oral composition | |
JP3951085B2 (en) | Dentifrice composition | |
US9084903B2 (en) | Compositions comprising alginates with high guluronic acid/mannuronic acid ratio for use in the treatment of dentine hypersensitivity | |
JP7200933B2 (en) | dentifrice composition | |
US9452124B2 (en) | Oral care composition for enhancing delivery of active agents to mucosa/soft oral tissue and tooth surfaces in the oral cavity | |
CN110691581B (en) | Dentifrice composition | |
JP6394360B2 (en) | Self-foaming dentifrice | |
JP6728302B2 (en) | Composition for interdental brush | |
JP2018104374A (en) | Toothpaste composition | |
JP2021054765A (en) | Oral composition | |
JP2022076813A (en) | Composition for oral cavity | |
JP2022104234A (en) | Composition for oral cavity | |
WO2018221620A1 (en) | Dentifrice composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230928 |